November, 2005

,

Human Growth Hormone: Responses in Severe Heart Failure+

Catherine Demers Recombinent human growth hormone has achieved clinical responses when used for treating heart failure. Catherine Demers of McMaster University told the American...

Read More+

,

Diabetic Patients: Some Benefits from Fibrates+

Anthony Keech Among nearly 10 000 patients with maturity onset diabetes the use of fenofibrate to lower cholesterol produced a 24 per cent statistically...

Read More+

,

COMMENTS+

Judith Hochman from New York University told Audio Medica that patients taking aspirin need to take it half an hour before any NSAID in...

Read More+

,

NSAIDs Raise Death Risk post-MI+

Gunnar Gislason As the dust continues to settle on the Vioxx issue, there is naturally a desire to look further at potential cardiovascular risks...

Read More+

,

Lytics before PCI: ASSENT Denied+

Frans van der Werf Near-complete data from the ASSENT-4-PCI trial investigating facilitated PCI (combining both thrombolysis and primary PCI after acute myocardial infarction) has...

Read More+

,

Withholding Abciximab Infusion After Stenting+

Olivier Bertrand The use of abciximab perfusion after stenting was questioned at the American Heart Association meeting in Dallas. The EASY study found bolus...

Read More+

,

Levosimendan Improves Heart Failure Progression+

Milton Packer In the REVIVE trial the inotropic agent levosimendan has improved short-term outcome in acutely decompensated heart failure. Milton Packer from the University...

Read More+

,

COMMENTS+

Gordon Tomaselli Gordon Tomaselli commented on Milton Packer’s findings at the Dallas meeting of the American Heart Association. Click here for all the interviews...

Read More+

,

Hypertension: Pressure Different at the Centre+

Bryan Williams Bryan Williams, University of Leicester Measuring blood pressure with a cuff around the arm does not always give a clear picture of...

Read More+

,

REPAIR-AMI: Progenitor Cells Regenerate the Heart after Infarction+

Volker Schächinger Regeneration of the heart has been achieved by using bone-marrow derived stem cells after myocardial infarction among 200 patients. Volker Schächinger, University...

Read More+

,

COMMENTS+

Gordon Tomaselli Gordon Tomaselli, Johns Hopkins School of Medicine Gordon Tomaselli commented on Volker Schächinger’s findings at the Dallas meeting of the American Heart...

Read More+